Eam Investors, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Eam Investors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $1.02 Million - $1.78 Million	-12,216 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $1.34 Million - $1.75 Million	12,216 New	12,216 $1.45 Million
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $2.19 Million - $3.26 Million	-21,989 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $203,532 - $286,015	-2,059 Reduced 8.56%	21,989 $3.05 Million
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $1.1 Million - $1.76 Million	16,762 Added 230.06%	24,048 $2.34 Million
Q1 2021 May 11, 2021	SELL	$64.07 - $91.75 $522,875 - $748,771	-8,161 Reduced 52.83%	7,286 $498,000
Q4 2020 Feb 11, 2021	SELL	$65.07 - $98.24 $19,846 - $29,963	-305 Reduced 1.94%	15,447 $1.32 Million
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $804,892 - $1.06 Million	-13,633 Reduced 46.39%	15,752 $1.02 Million
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $852,458 - $2.18 Million	29,385 New	29,385 $2.15 Million
Q3 2019 Nov 13, 2019	SELL	$37.38 - $49.47 $2.22 Million - $2.94 Million	-59,383 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $97,604 - $164,375	-2,453 Reduced 3.97%	59,383 $2.6 Million
Q1 2019 May 13, 2019	BUY	$34.52 - $53.29 $2.13 Million - $3.3 Million	61,836 New	61,836 $3.18 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.